ENZC & BIOCLONETICS IN FINAL STAGE!! FINAL STAGE!!! FINAL STAGE...DONT LOSE FOCUS HERE!!!
"BioClonetics is in the final stage of development of a parent monoclonal antibody (“mAb”) (designated as Clone 3), which is non-toxic and has shown in initial in vitro testing to be effective against more than 95% of all strains and viral subtypes of HIV-1 against which it has been tested."